Effect of curcumin supplementation in Patients with Polycystic ovarian syndrome
Not Applicable
- Conditions
- Health Condition 1: N832- Other and unspecified ovarian cysts
- Registration Number
- CTRI/2022/03/040866
- Lead Sponsor
- AIIMS RISHIKESH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Women with PCOS diagnosed by Rotterdam criteria.
2.Aged between 18-49 years
3. Patients who are willing to provide written informed consent.
Exclusion Criteria
1. Patients with hormonal disorders, autoimmune diseases, cancer, diabetes mellitus.
2. Pregnancy and lactating females.
3. Hyperprolactinemia.
4. Patients taking OCPs, antioxidants, multivitamin mineral oils, statins, Anti TNF drugs, glucocorticoids (any intervention that could alter insulin sensitivity, inflammation, or oxidative stress status).
5. Overt infections.
6. Women presenting with Infertility.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Homeostatic model assessment - insulin resistance (HOMA-IR) calculated as FI (microU/l) Ã? FPG (nmol/l)/22.5 among both groups.Timepoint: at baseline and after 3 months of intervention
- Secondary Outcome Measures
Name Time Method fasting plasma glucose, fasting insulin, QUICKI, LH, FSH, DHEAS, Testosterone, Hirsutism, Anthropometric parametersTimepoint: at baseline and after 3 months after intervention